IP Library › Granted Patent US 7,285,645
Granted Patent B2
US 7,285,645 · App. 10/187,887 · Granted Oct 23, 2007

PRO4356 antibodies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,285,645
App. No.
10/187,887
Granted
Oct 23, 2007
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (5)

1. An isolated antibody that binds specifically to the polypeptide of SEQ ID NO:476.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is a humanized antibody.

4. The antibody of claim 1 which is an antibody or fragment thereof.

5. The antibody of claim 1 which is labeled.

Assignments (1)
SECURITY AGREEMENT Recorded Jul 21, 2003
From: REGULOME CORPORATION
To: GATX VENTURES, INC.
Reel/Frame 014280/0526 →